Anthony Mark McCamish Net Worth & Insider Trades

Anthony Mark McCamish - Director, Avadel Pharmaceuticals Plc

As of August 5, 2022

What is Anthony Mark McCamish's Net Worth?

The current estimated net worth of Avadel Pharmaceuticals Plc's Director, Anthony Mark McCamish, is estimated to be about $5.49M . Anthony Mark McCamish owns about 171,000 units of Avadel Pharmaceuticals Plc common stock. In the last 2 years at Avadel Pharmaceuticals Plc, Anthony Mark McCamish has sold an estimated value of $0 worth.

What is Anthony Mark McCamish's Past Insider Trading?

Anthony Mark McCamish's largest purchase order was 171,000 units , worth over $985.22K on September 18, 2020. In total, Anthony Mark McCamish has made about 5 transactions over 2 years of their time at Avadel Pharmaceuticals Plc. Anthony Mark McCamish usually trades in August, with the busiest year in 2020.

Anthony Mark McCamish

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Anthony Mark McCamish's' Mailing Address?

  • Mailing address is C/o Forty Seven, Inc. 1490 O'Brien Drive, Suite A Menlo Park CA 94025 CA

Avadel Pharmaceuticals Plc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Gregory J. Divis 2020 $520,000 - $2,246,694 $3,143,694 $23,400 $3,143,694
Gregory J. Divis 2019 $472,292 $33,300 $485,010 $1,436,262 $23,316 $1,436,262
Gregory J. Divis 2018 $417,178 - $198,500 $685,428 $23,000 $685,428
Thomas S. McHugh 2020 $385,000 - $898,678 $1,479,878 $11,400 $1,479,878
Thomas S. McHugh 2019 $33,688 - $469,600 $503,288 - $503,288
Jordan S. Dubow 2020 $368,756 - $254,604 $859,740 $236,381 $859,740
Jordan S. Dubow 2019 $293,296 - $273,258 $743,224 $10,282 $743,224
Phillandas T. Thompson 2020 $310,594 - - $850,652 $417,041 $850,652
Phillandas T. Thompson 2019 $383,400 $33,300 $103,250 $698,157 $21,780 $698,157
Phillandas T. Thompson 2018 $365,968 - - $450,378 $20,000 $450,378
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1012477/000110465921059020/tm212548-2_def14a.htm

What are Avadel Pharmaceuticals Plc's Past Insider Trades?

Avadel Pharmaceuticals Plc's most recent insider trade came on November 23, 2022 by Eric Ende who bought 20,000 units worth $156.05K . In the last 5 years, insiders at Avadel Pharmaceuticals Plc have sold an estimated value of $6.27M and bought an estimated value of $5.26M worth of shares. Insider trading is most common in January, with the busiest year in 2017. The most active traders at the company are Eric Ende, Director,  Craig R Stapleton, Director,  and Michael Geoffrey Glass, Director .

AVADEL PHARMACEUTICALS PLC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1